Lauren Lieberman

Feb 26, 2026

Target

$32.00

Current

$30.15

Performance

Lauren Lieberman rated KDP as Equal-Weight on Feb 26, 2026, setting a price target of 32. The Hold stance appears justified, as shares hovered around 30.15 with a % move.

ODD

Feb 26, 2026

Target

$40.00

Current

$14.74

Performance

On Feb 26, 2026, ODD was given a Underweight rating by Lauren Lieberman, with a target price of 40. The stock traded sideways with only a % move, leaving the Sell case unresolved.

CCEP

Feb 19, 2026

Target

$111.00

Current

$108.24

Performance

3.38%

CCEP received a Overweight rating from Lauren Lieberman on Feb 19, 2026, aiming for 111. Price action was muted, as shares hovered around 108.24 despite the bullish outlook.

IFF

Feb 17, 2026

Target

$91.00

Current

$79.88

Performance

-3.46%

On Feb 17, 2026, Lauren Lieberman published a Overweight outlook on IFF, with a target of 91. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 79.88.

KO

Feb 12, 2026

Target

$83.00

Current

$80.47

Performance

1.86%

Lauren Lieberman on Feb 12, 2026 assigned KO a Overweight rating, with a price target of 83. The recommendation remains pending validation as shares consolidate around 80.47.

EPC

Feb 10, 2026

Target

$21.00

Current

$22.40

Performance

9.27%

On Feb 10, 2026, Lauren Lieberman reaffirmed EPC with a Equal-Weight rating, targeting 21. Market strength beyond 22.4 went further than the conservative outlook suggested.

EL

Feb 09, 2026

Target

$94.00

Current

$112.92

Performance

14.05%

EL was rated Equal-Weight by Lauren Lieberman on Feb 09, 2026, with a price objective of 94. Despite caution, upside momentum rewarded risk-takers with gains to 112.92.

COTY

Feb 09, 2026

Target

$2.50

Current

$2.65

Performance

3.92%

On Feb 09, 2026, Lauren Lieberman initiated coverage on COTY with a Underweight rating and target of 2.5. Sideways trading kept the bearish case unconfirmed with the stock at 2.65.

CL

Feb 03, 2026

Target

$88.00

Current

$96.67

Performance

3.78%

Lauren Lieberman issued a Equal-Weight recommendation for CL on Feb 03, 2026, price target set at 88. The rating was appropriate for a consolidating market trading near 96.67.

STZ

Jan 12, 2026

Target

$148.00

Current

$155.12

Performance

2.17%

On Jan 12, 2026, STZ was evaluated by Lauren Lieberman, who gave a Equal-Weight rating and target of 148. Hold sentiment was validated by subdued trading with no breakout beyond 155.12.

PEP

Dec 11, 2025

Target

$144.00

Current

$169.17

Performance

13.51%

Lauren Lieberman rated PEP as Equal-Weight on Dec 11, 2025, setting a price target of 144. Despite the Hold call, shares climbed 13.51% to 169.17, revealing unexpected momentum.

PRMB

Nov 26, 2025

Target

$25.00

Current

$19.63

Performance

25.59%

On Nov 26, 2025, PRMB was given a Overweight rating by Lauren Lieberman, with a target price of 25. The stock rallied 25.59% after the rating, narrowing the gap to the target of 25 and validating the bullish stance.

KVUE

Nov 10, 2025

Target

$18.00

Current

$18.77

Performance

11.93%

KVUE received a Equal-Weight rating from Lauren Lieberman on Nov 10, 2025, aiming for 18. Investors saw gains of 11.93% that the cautious stance didn’t fully capture.

OLPX

Nov 10, 2025

Target

$1.25

Current

$1.65

Performance

44.74%

On Nov 10, 2025, Lauren Lieberman published a Equal-Weight outlook on OLPX, with a target of 1.25. The Hold call missed some of the bullish momentum as shares advanced toward 1.25.

TAP

Nov 06, 2025

Target

$45.00

Current

$47.51

Performance

7.76%

Lauren Lieberman on Nov 06, 2025 assigned TAP a Underweight rating, with a price target of 45. The market validated the bearish call with a pullback to 47.51.

CHD

Nov 04, 2025

Target

$82.00

Current

$103.63

Performance

19.67%

On Nov 04, 2025, Lauren Lieberman reaffirmed CHD with a Underweight rating, targeting 82. The Sell recommendation anticipated weakness, as shares dropped 19.67%.

PG

Oct 01, 2025

Target

$153.00

Current

$163.39

Performance

6.67%

PG was rated Equal-Weight by Lauren Lieberman on Oct 01, 2025, with a price objective of 153. Despite caution, upside momentum rewarded risk-takers with gains to 163.39.

KMB

Oct 01, 2025

Target

$131.00

Current

$109.21

Performance

-11.38%

On Oct 01, 2025, Lauren Lieberman initiated coverage on KMB with a Equal-Weight rating and target of 131. The rating matched the stock’s inability to hold above 109.21.

CLX

Oct 01, 2025

Target

$112.00

Current

$126.24

Performance

2.90%

Lauren Lieberman issued a Underweight recommendation for CLX on Oct 01, 2025, price target set at 112. Investors remain in wait-and-see mode as shares stayed flat.

ENR

Aug 06, 2025

Target

$27.00

Current

$21.85

Performance

-26.46%

On Aug 06, 2025, ENR was evaluated by Lauren Lieberman, who gave a Equal-Weight rating and target of 27. The Hold call avoided chasing into subsequent weakness of 26.46%.

REYN

Aug 01, 2025

Target

$22.00

Current

$24.64

Performance

11.80%

Lauren Lieberman rated REYN as Equal-Weight on Aug 01, 2025, setting a price target of 22. Despite the Hold call, shares climbed 11.80% to 24.64, revealing unexpected momentum.

NOMD

Mar 03, 2025

Target

$23.00

Current

$12.33

Performance

-37.85%

On Mar 03, 2025, NOMD was given a Overweight rating by Lauren Lieberman, with a target price of 23. Despite the Buy call, shares fell from 12.33 to 12.33, challenging the optimistic stance.

NWL

Jan 17, 2025

Target

$11.00

Current

$4.56

Performance

-54.94%

NWL received a Overweight rating from Lauren Lieberman on Jan 17, 2025, aiming for 11. The rating hasn’t played out as hoped, with the stock trading 54.94% below expectations.

LW

Dec 23, 2024

Target

$60.00

Current

$47.08

Performance

-26.32%

On Dec 23, 2024, Lauren Lieberman published a Overweight outlook on LW, with a target of 60. Market action contradicted the Buy thesis, as shares slipped to 47.08.

FIVN

Dec 18, 2024

Target

$46.00

Current

$17.85

Performance

-56.72%

Lauren Lieberman on Dec 18, 2024 assigned FIVN a Equal-Weight rating, with a price target of 46. The call successfully avoided chasing as shares lost 56.72%.

BRBR

Nov 21, 2024

Target

$79.00

Current

$18.06

Performance

-76.39%

On Nov 21, 2024, Lauren Lieberman reaffirmed BRBR with a Overweight rating, targeting 79. Shares slid 76.39% despite the recommendation, highlighting downside risks.

NAPA